Flow of participants in the Delphi survey. av Beatriz Goulão (16498275)

“…Four items reached consensus regarding critical importance for patient and public involvement: presentation of results to trial participants; summary and presentation of harms; interpretation and presentation of findings in an academic setting; factors impacting how well a treatment works. …”

S1 Data - av John Twomey (12595255)

Ämnen:

Prevalence of tweets over time in the dataset. av John Twomey (12595255)

Ämnen:

Timeline of the use of deepfakes/synthetic media in the war. av John Twomey (12595255)

Ämnen:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. av Meagan Lacroix (16698830)

Ämnen:

Baseline characteristics of physicians and patients–prescribers in top 25 percent. av Meagan Lacroix (16698830)

Ämnen:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention–sensitivity analysis. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered to patients >65 at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention for patients > 65. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Estimates of percent change in slope of total benzodiazepine prescriptions after the intervention vs before. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of high-risk benzodiazepine prescriptions at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Flow diagram of included AD physicians. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered to patients >65 at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen:

Mean rate (per 100) of long-term benzodiazepine prescriptions at 12 months pre- to 18 months post-intervention. av Meagan Lacroix (16698830)

Ämnen: